Regen BioPharma Inc (RGBP)

[cvinvestor]

RGBP licensed a good portion of its intellectual property after doing nothing with it for several years while Koos just issues millions of shares to live his life.

Looks like he got a good deal, but other than the 50,000 shares of ONPH, worth approx 1.5M (significant for RGBP which has only bled for years (I know as a shareholder back in the days of HemaXellerate development), what is the near term value or event that is going to keep the share price afloat?

$1.5M in share value, if sold, would just be used by Koos to pay himself salary, issue more stock to himself to buy at .01 or .001 so that he can sell it along the way to buy what he wants.

That's been the pattern for years. Look at all the companies and sub-companies he continues to create for legal gymnastics for his own purposes.

If ONPH actually develops the technology into useful treatments, then I agree there is potential, depending on how much debt has to be repaid etc. But over the next 12 months, what do people see being the reason RGBP goes to .50? I must be missing something.